Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11903922
Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders
granted -
US 11905297
OX2R compounds
granted -
US 11904054
Compositions and methods for delivering pharmaceutical agents
granted -
WO 2024033462
CELLULES SOUCHES MÉSENCHYMATEUSES À UTILISER DANS LE TRAITEMENT DE L'HYPERSENSIBILITÉ AUX PIQÛRES D'INSECTES CHEZ DES ÉQUIDÉS
granted -
US 11896672
Targeted nucleic acid conjugate compositions
granted -
US 11896658
RSV vaccines and methods of production and use thereof
granted -
US 11896654
DNA monoclonal antibodies targeting checkpoint molecules
granted -
US 11897945
Methods of treating allergy using anti-Bet v 1 antibodies
granted -
US 11898165
Engineered host cells and methods of use thereof
granted -
US 11896623
Visco-supplement compositions, and methods of use thereof
granted -
US 11896603
Oligosaccharide as therapeutic agent for alcohol associated liver disease
granted -
US 11896599
Modified release preparations containing oxcarbazepine and derivatives thereof
granted -
US 11896626
Multistrain population control systems and methods
granted -
US 11898166
In vitro generation of thymic organoid from human pluripotent stem cells
granted -
US 11896007
Pest control using natural pest control agent blends
granted -
US 11898207
Methods of isolating neoantigen-specific T cell receptor sequences
granted -
US 11896617
Polynucleotides encoding rituximab-resistant chimeric antigen receptors
granted -
US 11896643
Fibroblast binding agents and use thereof
granted -
US 11897879
Heterocyclic compound
granted -
US 11897873
Kappa opioid receptor antagonists and products and methods related thereto
granted -
US 11898158
Methods and compositions for the treatment of lysosomal storage diseases
granted -
US 11897932
Receptors for ligand-dependent transcriptional regulation
granted -
US 11896417
Time-varying kinetic modeling of high temporal-resolution dynamic pet data for multiparametric imaging
granted -
US 11896558
Use of an RXR agonist and taxanes in treating Her2+ cancers
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.